The ICAD Principles

• I1. Every instrument output is captured at the point of generation — not exported manually, not aggregated after the fact.
• I2. Raw data is preserved in its native format with full provenance to source system, timestamp, and operator.
• I3. Integration is industrialized — each build creates a reusable asset that reduces the cost and time of the next integration.
• I4. New instruments are onboarded in days, not months — the integration pipeline is a factory, not a project.

What it enables
Instrument data from any vendor, any format, any site enters a governed pipeline — eliminating manual exports, CSV transfers, and site-specific data silos. Each new instrument connected enriches the dataset available to every downstream step in the sequence.

• C1. Data is linked to its scientific context — method, sample, experiment, study, program, and regulatory submission.
• C2. Master data is reconciled across sites, systems, and naming conventions — one identity per entity, globally.
• C3. Lineage traces every data point from instrument through transformation to decision, with no gaps.
• C4. Context is machine-readable — not trapped in PDF reports, Electronic Laboratory Notebook (ELN) narratives, or spreadsheet column headers.

What it enables
Scientists query across programs, sites, and therapeutic areas using scientific terms — not system identifiers. Regulatory teams trace any data point from submission back to the originating instrument run. Master data reconciliation eliminates the “same compound, five names” problem that plagues multi-site R&D.

• A1. Analysis operates on contextualized data, never on raw instrument output alone — context is a prerequisite.
• A2. Cross-program comparisons are governed — same method, same context rules, same statistical framework.
• A3. Statistical models are traceable to their training data with full provenance — no black-box analytics.
• A4. Insights are reproducible — any analyst, any site, same governed dataset produces the same result.

What it enables
Out-of-specification (OOS) investigations that previously took weeks complete in hours because root-cause analysis operates on governed, cross-referenced data. Method transfers between sites carry full lineage. Stability trending spans programs and geographies. Analytical method comparisons are reproducible by any qualified analyst at any site.

• D1. AI operates only on data that has passed through I→C→A — never on ungoverned, decontextualized inputs.
• D2. Every AI recommendation is traceable to its source data, analytical provenance, and decision logic.
• D3. Autonomy is configurable per decision type — from fully autonomous execution for routine operations to human-in-the-loop approval where regulatory classification or risk profile requires it.
• D4. Decisions feed back into the sequence — improving integration targets, context models, and analytical frameworks.

What it enables
Investigational New Drug (IND) application compilation draws on governed data across disciplines — no manual assembly from disconnected systems. Chemistry, Manufacturing, and Controls (CMC) sections reference live, traceable analytical data. Laboratory workflows close the loop from experiment design through execution to result — with configurable autonomy that scales from full automation for routine operations to human-gated approval where Good Practice (GxP) classification requires it. Shelf-life predictions and trend analyses operate on complete, multi-program datasets rather than single-study snapshots.